Authors: Luesley, D

Citation: D. Luesley, Improving outcomes in gynaecological cancers, BR J OBST G, 107(9), 2000, pp. 1061-1063

Authors: Herod, J Burton, A Buxton, J Tobias, J Luesley, D Jordan, S Dunn, J Poole, CJ

Citation: J. Herod et al., A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versusradiotherapy alone in inoperable cancer of the cervix, ANN ONCOL, 11(9), 2000, pp. 1175-1181

Authors: Poole, CJ Perren, T Burton, A Jordan, SD Jenkins, AH Mould, JJ Spooner, DA Luesley, D Chan, KK Sturman, S Earl, HM

Citation: Cj. Poole et al., Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovariancancer, ANN ONCOL, 11(12), 2000, pp. 1603-1608

Authors: Teale, G Etherington, I Luesley, D Jordan, J

Citation: G. Teale et al., An audit of standards and quality in a teaching hospital colposcopy clinic, BR J OBST G, 106(1), 1999, pp. 83-86

Authors: Kehoe, S Luesley, D

Citation: S. Kehoe et D. Luesley, Vulvar vestibulitis treated by modified vestibulectomy, INT J GYN O, 64(2), 1999, pp. 147-152

Authors: Cope, G Thorpe, G Holder, R Luesley, D Jordan, J

Citation: G. Cope et al., Serum and tissue antioxidant capacity in cervical intraepithelial neoplasia investigated using an enhanced chemiluminescent reaction, ANN CLIN BI, 36, 1999, pp. 86-93